Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Du bruger tilsyneladende en bredere skærm. Vil du gerne give denne side en bredere visningsoplevelse?

Qlife Holding – Introduction to market segment and demonstration of Egoo

Af HC Andersen Capital
Qlife Holding

Meet Qlife Holding’s CEO Thomas Warthoe who will tell us more about one of their segments; dieticians & nutritionist, who are dealing with patients with systemic low-grade inflammation, what it is, and what solution the company offer to this.

This event will explain one of the main drivers for Qlife and Egoo Health.

Inflammation is defined by increased CRP levels. Low-grade inflammation is defined with CRP levels 3-10 mg/L. Low-grade inflammation can be caused by an unhealthy lifestyle that includes smoking, a poor diet, alcohol consumption, stress, and weight gain.

A CRP quantitative test was launched on the Egoo System earlier this year to allow monitoring of inflammation levels and to target this growing lifestyle market. 

The event takes place on the 15th of June at 10.00 am CEST. After the presentation, you are more than welcome to ask questions.

Qlife Holding strives to revolutionize the market for clinical biomarkers. The company has developed Egoo Health which is a nextgen self-testing at-home biomarker platform. It is designed to simplify testing procedures for at-home test scenarios. The C-Reactive Protein (CRP) test is launched and can be ordered on www.egoo.health/egoo-shop. Other clinical lifestyle biomarker tests such as HbA1c, Lipids, Vitamin D, hormones, and more will be launched continuously.

The company is on a quest to empower people with more accessible ways to understand their health - so that they can move beyond reactive care towards proactive wellbeing. It's how Qlife wants to contribute to improving quality of life for every individual and for the greater society.

Disclaimer: HC Andersen Capital receives payment from Qlife Holding for a DigitalIR/Corporate Visibility agreement./ Claus Thestrup 6 June 2023 at 2:PM.

Seneste videoer

Nordic Bloom - Live fra Silicon Valley: Mød Jared Heyman fra Rebel Fondene
10.03.2026, 15.00
Gubra – Presentation of Phase 1 Topline Results on ABBV-295 long-acting amylin analog
10.03.2026, 13.30 Gubra
Hanza, Capital Markets Day, CMD, 2026
10.03.2026, 13.00 HANZA
HCA Morgenbørs 09/03 - Et store fald på futures fronten, oliepriser har krydset 100 og øget nervøsitet omkring finansiering af AI udbygningen
10.03.2026, 09.26 Torm
HCA Morgenbørs 10/03 - Europæiske futures indikerer et re-bound
10.03.2026, 09.15 Rockwool
Vis alle videoer
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.